How is the vaccine rollout progressing?

Following several consecutive announcements of vaccine candidate success in November 2020, markets began pricing in an end to the COVID-19 pandemic. Shortly after these vaccines were deemed effective, many were fast-tracked for approval by governments around the world, and vaccination programs began in earnest in December of last year. Now, in the second month of 2021, many investors may be wondering: how is the vaccine rollout progressing, and how close is the pandemic to being over?

Om Podcasten

Listen to the latest insights from Dr. David Kelly, Chief Global Strategist at J.P. Morgan Asset Management to help prepare you for the week ahead.